Xencor Inc (XNCR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.66B
Last updated: Nov 17, 2026 at 4:33 PM ET
Xencor Inc (XNCR) Statistics
Xencor (XNCR) has a market cap of $2.66B and an enterprise value of $2.69B. It kept -58.79% of revenue as net income over the last 12 months. Revenue grew 33.55% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 1.33% above the market cap, as debt exceeds cash.
| Market Cap | $2.66B |
|---|---|
| Enterprise Value | $2.69B |
| Latest price (Nov 17, 2026) | $34.50 |
Key Dates
The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 13.1x and 4.7x. Its year-end P/S ranged from 7.3x to 49.9x from 2016 to 2025.
| P/S Ratio | 13.1x |
|---|---|
| Forward P/S | 13.2x |
| P/B Ratio | 4.7x |
| P/TBV Ratio | 4.7x |
Price Statistics
The stock is up 131.08% over 52 weeks and trades 24.55% above its 50-day average.
| Beta (1Y) | 1.31 |
|---|---|
| 52-Week Change | +131.08% |
| 1-Month Change | +48.77% |
| 3-Month Change | +25.36% |
| 6-Month Change | +231.41% |
| 5-Year Change | -24.62% |
| 10-Year Change | +40.07% |
| Total Return (1Y) | +131.08% |
| Total Return (3Y CAGR) | +21.53% |
| Total Return (5Y CAGR) | -1.37% |
| Return vs SPY (1Y) | +103.80% |
| Max Drawdown (1Y) | -42.61% |
| Max Drawdown (3Y) | -73.92% |
| Sharpe Ratio (1Y) | 1.20 |
| Correlation with SPY (1Y) | 0.28 |
| 50-Day Average | $27.70 |
| 200-Day Average | $18.33 |
| 52-Week Range | $10.38 to $40.60 |
| RSI (14 Days) | 58.2 |
| Average Volume (20 Days) | 1.80M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 6.54x current liabilities, and total debt is 0.17x shareholder equity.
| Current Ratio | 6.54x |
|---|---|
| Quick Ratio | 6.54x |
| Debt / Equity | 0.17x |
| Interest Coverage | -4.82x |
Returns and Efficiency
Return on invested capital is -17.30% over the last 12 months, against a 5-year average of -15.60%.
| Return on Equity (ROE) | -21.03% |
|---|---|
| Return on Assets (ROA) | -15.30% |
| Return on Invested Capital (ROIC) | -17.30% |
| Return on Capital Employed (ROCE) | -16.33% |
| ROE (5Y Average) | -13.17% |
| ROA (5Y Average) | -8.07% |
| ROIC (5Y Average) | -15.60% |
| Asset Turnover | 0.24x |
| Receivables Turnover | 3.75x |
Scores
XNCR has an Altman Z-Score of 6.29, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 6.29 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $200.49M over the last 12 months.
| Revenue | $200.49M |
|---|---|
| Revenue Growth (YoY) | +33.55% |
| Gross Profit | $200.49M |
| Operating Income | -$145.69M |
| Pretax Income | -$115.56M |
| Net Income | -$117.86M |
| EBITDA | -$104.00M |
| EBIT | -$113.40M |
| Reported EPS (TTM) | -$1.59 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 72.74% of the $770.50M in total assets.
| Cash and Equivalents | $59.62M |
|---|---|
| Total Debt | $95.06M |
| Net Debt | $35.44M |
| Net Debt Per Share | $0.46 |
| Working Capital | $422.39M |
| Shareholder Equity | $560.43M |
| Book Value Per Share | $7.35 |
| Tangible Book Value | $555.38M |
| Tangible Book Per Share | $7.29 |
| Total Assets | $770.50M |
| Total Liabilities | $210.07M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $4.09M of capital spending, operating cash flow left -$176.45M of free cash flow.
| Operating Cash Flow | -$172.35M |
|---|---|
| Capital Expenditures | $4.09M |
| Free Cash Flow | -$176.45M |
| FCF Per Share | -$2.37 |
| Depreciation and Amortization | $10.34M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -72.67%, against a 5-year average of -82.56%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -72.67% |
| Pretax Margin | -57.64% |
| Net Margin | -58.79% |
| EBITDA Margin | -51.87% |
| EBIT Margin | -56.56% |
| FCF Margin | -88.01% |
| Operating Margin (5Y Average) | -82.56% |
| Net Margin (5Y Average) | -73.46% |
Growth
Revenue fell 8.62% a year over 3 years.
| Revenue Growth (3Y CAGR) | -8.62% |
|---|---|
| Revenue Growth (5Y CAGR) | +0.47% |
| Book Value Per Share Growth (2Y CAGR) | -11.27% |
| Tangible Book Per Share Growth (2Y CAGR) | -10.59% |
Dividends and Yields
XNCR does not pay a dividend. Its free cash flow yield is -6.71%.
| FCF Yield | -6.71% |
|---|---|
| Buyback Yield | -0.70% |
| Shareholder Yield | -0.70% |
Peer Position
Against 7 similar companies, XNCR has the 2nd highest P/S.
P/S RatioPeer median 5.2x
ROICPeer median -25.19%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -34.33%
| P/S Ratio | 13.1x vs 5.2x median |
|---|---|
| ROIC | -17.30% vs -25.19% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +33.55% vs -34.33% median |
Analyst Forecast
Consensus estimates put revenue growth at -3.72% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -3.72% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About XNCR
What is XNCR's market cap?
Xencor has a market cap of $2.66B. Its enterprise value, which adds debt and subtracts cash, is $2.69B.
How many shares of XNCR are outstanding?
Xencor has 76.22M shares outstanding. The count is up 2.42% from a year earlier.
Does XNCR pay a dividend?
No. Xencor does not pay a dividend.
How much debt does XNCR have?
Xencor has $95.06M of total debt and $59.62M of cash and equivalents, a net debt position of $35.44M.
XNCR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors